Member May: Advances in Clinical Application of Extracorpal shockwave therapy (ESWT)-Session Recording

Video Transcription

Video Summary

The session, led by Haruki Ishii, a clinical assistant professor at NYU Langdon Hospital, delves into the application of shockwave therapy on musculoskeletal (MSK) conditions. Shockwave therapy, a non-invasive intervention that utilizes sound or pressure waves to stimulate biological responses, can induce benefits such as increased collagen synthesis and tissue healing. The therapy is categorized into focal and radial shockwaves, with focal shockwaves reaching deeper tissues, beneficial for tendons and bones, while radial shockwaves are suited for surface-level soft tissue stimulation.<br /><br />Ishii outlined the clinical applications of shockwave therapy in various MSK disorders including tendinopathies, osteoarthritis, bone stress injuries, and muscle injuries, providing evidence from multiple studies highlighting its efficacy. Shockwave therapy has seen FDA approval for conditions like lateral epicondylitis and plantar fasciitis, and improvements have been noted in functions and pain relief in conditions like rotator cuff tendinopathy and Achilles tendinopathy. Despite their benefits, shockwave treatments are generally recommended as a supplementary treatment alongside other interventions like physical therapy. Ishii also touched on logistics, noting that shockwave procedures require minimal downtime and involve limited adverse effects, making them an attractive option for athletes seeking to recover without extended periods away from activity.

Keywords

shockwave therapy

musculoskeletal conditions

Haruki Ishii

collagen synthesis

tissue healing

tendinopathies

FDA approval

athlete recovery

non-invasive treatment